Patent Yard Sign in
European application, no grantEurope

A pyrrolidineacetamide derivative alone in combination for treatment of CNS disorders

EP 1600167 A2 · Applicant: UCB, S.A.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed November 27, 2000 and never granted as a European patent. Had it been granted, its 20-year term would have ended November 27, 2020.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by May 27, 2026.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledNovember 27, 2000
PublishedNovember 30, 2005
GrantedNever granted
Term endedNovember 27, 2020
Application numberEP 05019209
Classification (CPC)A61P25/00 +2 more

Timeline

Timeline From EPO dates

2001200320052007200920112013201520172019Application filedNov 27, 2000PublishedNov 30, 2005Term endedNov 27, 2020

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.